KDM1A and breast cancer: For example, MC3324 (a dual-KDM inhibitor against LSD1 and UTX) up-regulates H3K4me2 and H3K27me3, which caused growth arrest and apoptosis in both hormone-responsive and insensitive BC cells by inhibiting ERα signaling (Benedetti et al., 2019).